ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

5-Bromoisoquinoline → Isoquinoline, 5-bromo-, 2-oxide

HRID 875043
印刷

反応式

HRID 875043 の反応式
[Br:1][C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][N:6]=[CH:7]2.O.O.O.O.O.O.C(O[O-])(=O)C1C(=CC=CC=1)C([O-])=[O:22].[Mg+2]>CC(O)C>[Br:1][C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][N+:6]([O-:22])=[CH:7]2
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 7364875-BromoisoquinolineHCID 21894687Magnesium 2-(dioxidan-2-ide-1-carbonyl)benzoate--water (1/1/6)

生成物 1

HCID 22665708Isoquinoline, 5-bromo-, 2-oxide

試薬・触媒・溶媒 1

HCID 3776Isopropanol溶媒

実験手順

3.1 A suspension of 6.24 g (30.0 mmol) of 5-bromoisoquinoline and 17.5 g (30 mmol) of magnesium monoperoxyphthalate hexahydrate (85%) in 120 ml of 2-propanol is stirred at room temperature for 50 hours. The reaction mixture is evaporated in vacuo, and saturated sodium chloride solution, saturated sodium hydrogencarbonate solution and dichloromethane are added. The organic phase is separated off and washed a number of times with saturated sodium chloride solution. The organic phase is dried over sodium sulfate and evaporated. The residue is stirred with tert-butyl methyl ether, giving 5-bromoisoquinoline 2-oxide as colourless crystals; HPLC/MS: 1.51 min, [M+H] 224/226.

後処理

  1. customThe reaction mixture is evaporated in vacuo, and saturated sodium chloride solution, saturated sodium hydrogencarbonate solution and dichloromethane
  2. additionare added
  3. customThe organic phase is separated off
  4. washwashed a number of times with saturated sodium chloride solution
  5. dry with materialThe organic phase is dried over sodium sulfate
  6. customevaporated
  7. stirringThe residue is stirred with tert-butyl methyl ether

出典と根拠

ORDレコード
ord-16498351d1074d418446eca756809d60
出典データセット
uspto-grants-2015_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08981101B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート